Japan, Aug. 6 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'INTRALESIONAL ADMINISTRATION OF PD-1 INHIBITORS FOR TREATING SKIN CANCER.' Other related details are as follows:

Application Number: JP,2024-102591

Category (FI): A61K39/395@U,A61K45/00,A61P35/00,A61P17/00,A61K39/395@T,A61P43/00,111

Stage: Grant (IP right granted following substantive examination.)

Filing Date: June 26, 2024

Publication Date: Sept. 10, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....